
Syntis Bio has appointed Matthew Dallas as Chief Financial Officer (CFO). Dallas brings more than 25 years of financial expertise …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

